China’s Leading Respiratory Disease Expert Warns Sinovac, Sinopharm Vaccines Vulnerable to South African Variant

China’s famed respiratory disease expert Zhong Nanshang (photo) issued a new warning over the weekend about the vulnerabilities of Chinese COVID-19 vaccines that use so-called inactive agents and their ability to hold up against new variants.

Zhong acknowledged at a medical forum on Saturday that both Sinopharm and Sinovac vaccines showed reduced efficacy against the B.1.351 variant that was first detected in South Africa.

This is the second time in just over two weeks that a senior Chinese public health official has acknowledged efficacy issues related to its COVID-19 vaccines.

The key issue here is that the mRNA method used by Pfizer and Moderna has been proven to be more effective than the less sophisticated Chinese jabs that use inactive agents to generate an immune response.

Read more on Zhong’s comments on the Global Times website.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Connect with leading professionals on the China- Africa Experts Network.

You've reached your free monthly article limit.

Subscribe today for unlimited access.

The post China’s Leading Respiratory Disease Expert Warns Sinovac, Sinopharm Vaccines Vulnerable to South African Variant appeared first on The China Africa Project.



source https://chinaafricaproject.com/2021/04/26/chinas-leading-respiratory-disease-expert-warns-sinovac-sinopharm-vaccines-vulnerable-to-south-african-variant/

Comments

Popular posts from this blog

China Angry With Japan Over G7 Joint Statement, Labels Accusations as “Hype”

The Growing Influence of Chinese Policing in Africa

Papua New Guinea, Micronesia to Sign Agreement With U.S. as Pacific Island Countries Increasingly Take Sides in Great Power Rivalry